Ignite Creation Date:
2025-12-24 @ 7:54 PM
Ignite Modification Date:
2026-03-07 @ 2:28 PM
Study NCT ID:
NCT01970904
Status:
COMPLETED
Last Update Posted:
2016-04-20
First Post:
2013-09-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
Sponsor:
Debiopharm International SA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CDEB025A2222
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None